Skip to main content
. Author manuscript; available in PMC: 2009 Sep 21.
Published in final edited form as: Ann Thorac Surg. 2008 May;85(5):1521–1526. doi: 10.1016/j.athoracsur.2008.01.078

Table 5.

Univariate and Multivariate Analysis for 30-Day Mortality

Treatment Effects (No Statin vs Statin) OR 95% CI p Value
Unadjusted 1.69 0.57–5.03 0.344
Univariate, adjusted
    For CVA 2.04 0.66–6.28 0.213
    For diabetes 2.04 0.66–6.36 0.218
    For renal failure 1.82 0.60–5.46 0.289
    For COPD 1.70 0.57–5.06 0.340
    For CVD 2.11 0.68–6.51 0.195
Multivariate, adjusted
    For all 5 risks 2.70 0.81–9.05 0.108

CI = confidence interval; COPD = chronic obstructive lung disease; CVA = cerebrovascular accident; CVD = cerebrovascular disease; OR = odds ratio.